2024/12/06 08:05:18 | |
---|---|
Price | |
184.00 EUR | |
Difference | -0.54% (-1.00) |
ISIN | US9139031002 |
Symbol | UHS |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,773 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 184.00 EUR |
High | 184.00 EUR |
Low | 184.00 EUR |
Close (prev. day) | 185.00 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 3 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/11/26 | Global Equity Ratings | ||
2024/11/19 | Global Equity Ratings | ||
2024/11/05 | Global Equity Ratings | ||
2024/10/29 | Global Equity Ratings | ||
2024/10/22 | Global Equity Ratings |
2024/12/06 08:05:18 | |
---|---|
Price | |
184.00 EUR | |
Difference | -0.54% (-1.00) |
ISIN | US9139031002 |
Symbol | UHS |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,773 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 184.00 EUR |
High | 184.00 EUR |
Low | 184.00 EUR |
Close (prev. day) | 185.00 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 3 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +6.36% | +44.88% | +64.73% |
Perf (abs.) | +11.00 | +57.00 | +72.30 |
Beta | 0.39 | 0.58 | 0.87 |
Volatility | 32.63 | 30.27 | 33.48 |
Ø price 5 days | Ø volume 5 days (pcs.) | 187.60 EUR (5) |
Ø price 30 days | Ø volume 30 days (pcs.) | 189.93 EUR (3) |
Ø price 100 days | Ø volume 100 days (pcs.) | 198.86 EUR (2) |
Ø price 250 days | Ø volume 250 days (pcs.) | 173.90 EUR (2) |
YTD High | date | 218.00 EUR (2024/10/17) |
YTD Low | date | 138.00 EUR (2024/01/02) |
52 Weeks High | date | 218.00 EUR (2024/10/17) |
52 Weeks Low | date | 124.00 EUR (2023/12/08) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/12/06 | 22:26 | 184.00 EUR | 0.00 | 1 |
Stuttgart | 2024/12/06 | 08:05 | 184.00 EUR | 0.00 | 3 |
NYSE | 2024/12/06 | 22:00 | 194.22 USD | 110.61 | 15,154 |
Munich | 2024/12/06 | 08:05 | 186.00 EUR | 0.00 | 2 |
Frankfurt | 2024/12/06 | 08:02 | 185.00 EUR | 0.00 | 2 |
Duesseldorf | 2024/12/06 | 19:30 | 181.00 EUR | 0.00 | 7 |
Berlin | 2024/12/06 | 08:08 | 184.00 EUR | 0.00 | 2 |
UNIVERSAL HEALTH SERVICES INC. |
- - |
Universal Corporate Center, 367 South Gulph Road - 19406-3121 King of Prussia |
Telefon: +1-610-768-3300 |
Fax: + |
E-mail: - |
Universal Health Services, Inc. engages in providing hospital and healthcare services. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Acute Care Hospital Services segment includes hospitals, freestanding emergency departments, and ambulatory centers. The Behavioral Health Care Services segment offers treatment programs for depression, anxiety, psychotic diagnoses, bipolar disorder, post-traumatic stress disorder, and neurorehabilitation. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA. |
Alan Miller | Chairman of Board of Directors |
Elliot Sussman | Member of Board of Directors |
Eileen McDonnell | Member of Board of Directors |
Maria Singer | Member of Board of Directors |
Nina Chen-Langenmayr | Member of Board of Directors |
Warren Nimetz | Member of Board of Directors |
Marc D. Miller | Chairman of Managing Board |
Alan B. Miller | Member of Executive Committee |
Matthew J. Peterson | Member of Executive Committee |
Steve G. Filton | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer